Intensity therapeutics ipo
WebOct 18, 2024 · Intensity Therapeutics, Inc (NASDAQ: INTS) IPO will take place October, 19 on the NASDAQ exchange under the ticker INTS. The company is offering shares at an expected price between $4.00 and $5.00 per share with an insider lock-up period of 180 days ending on April 17, 2024. Intensity Therapeutics, Inc is a clinical-stage biotechnology company ... WebApr 11, 2024 · Upcoming IPO Calendar 👀 See real-time options trading activity and uncover the smart money moves as they happen. Free Week Trial → WhaleStream Learn Education and Resources Dashboard Overview Stock Market Data Top Options Flow (live) Top Dark Pool & Equities Flow (live) Top Options Open Interest Changes Market Tracker Free Daily …
Intensity therapeutics ipo
Did you know?
WebOct 18, 2024 · Intensity Therapeutics, Inc INTS IPO will take place October, 19 on the NASDAQ exchange under the ticker INTS. The company is offering shares at an expected price between $4.00 and $5.00 per... WebSep 20, 2024 · Intensity Therapeutics, a Phase 2 biotech developing intratumoral injection therapies for cancer, announced new terms for its IPO on Tuesday. The Westport, CT-based company now plans to raise $10 million by offering 2.2 million shares at a …
WebOur Biotech IPO Calendar provides a brief rundown of upcoming biotech initial public offerings. The Historical Biotech IPO Database below tracks most listings over at least the previous 12 months. Data is generously supplied by IPOScoop.com No Upcoming IPOs. Lock up / Quiet Period IPO Expiry Data No IPO Pipeline Data WebApr 20, 2024 · Intensity Therapeutics, a Phase 1/2 biotech developing intratumoral injection therapies for cancer, filed a new blank prospectus with the SEC on Wednesday, with plans to raise $17 million. The company had most recently planned to raise $15 million by offering 2.1 million shares at a price range of $6 to $8.
WebDec 8, 2024 · December 8, 2024 Intensity Therapeutics, a Phase 1 biotech developing intratumoral injection therapies for cancer, revised the terms for its upcoming IPO on Wednesday. The Westport, CT-based company now plans to raise $15 million by offering 2.1 million shares at a price range of $6 to $8. WebSep 22, 2024 · Intensity Therapeutics has filed to raise $10 million in an IPO. The firm is developing intratumoral injection treatment approaches for various cancer conditions. Intensity Therapeutics...
WebDec 10, 2024 · Intensity Therapeutics is offering 2.1 million shares of its common stock in the IPO. The expected price range for the IPO is US$6-US$8 per share. Intensity Therapeutics has released a positive report for its lead proprietary investigational product candidate INT230-6.
WebPrior to joining Intensity Therapeutics, Dr. Walters spent seven years at Bristol-Myers Squibb (BMS), where he led the clinical research and matrix development teams. During his tenure at BMS, he contributed to the development of multiple immuno-oncology products including the anti-CTLA-4 compound Yervoy® (Impilimumab) and the anti-PD-1 ... crochet hair bows free patternsWebWelcome to /r/IPO a subreddit dedicated to news articles and S-1 filings for the newest IPOs. ... Search within r/IPO. r/IPO. Log In Sign Up. User account menu. Found the internet! 2. INTENSITY THERAPEUTICS, INC - S-1 IPO Investment Prospectus. Close. 2. Posted by 15 days ago. INTENSITY THERAPEUTICS, INC - S-1 IPO Investment Prospectus. sec ... crochet hair bows patternsWebSep 30, 2024 · Intensity Therapeutics, Inc. has completed an IPO in the amount of $8.1 million. MarketScreener Homepage Equities United States Nasdaq Intensity Therapeutics, Inc. News Summary INTS US45828J1034 INTENSITY THERAPEUTICS, INC. (INTS) Add to my list Summary Quotes News Company Financials Funds Summary Most relevant All … buffalo wild wings tucson azWebIn 2024, the Company executed a clinical collaboration agreement with Bristol Myers Squibb (BMS) to evaluate the combination of the Company’s lead product, INT230-6, with BMS’s anti-CTLA-4 antibody, Yervoy® (ipilimumab), in patients with advanced sarcoma, breast, and liver cancers. The cohorts are open to enrollment. crochet hair braids pricescrochet hair box braidWeb24 rows · Feb 13, 2024 · On Dec. 31, 2024, Intensity posted a cash and cash equivalents balance of $9.316 million. However, ... crochet hair braiders near meWebSep 21, 2024 · Drug delivery developer Intensity Therapeutics ( INTS) has disclosed more terms for a proposed $10M initial public offering. The company said in a filing that it's now considering offering 2.2M... crochet hair braiding near me